{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T04:12:04Z","timestamp":1763093524120,"version":"3.45.0"},"reference-count":30,"publisher":"The Korean Society of Pathologists and The Korean Society for Cytopathology","issue":"6","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpatholtm.org"],"crossmark-restriction":true},"short-container-title":["J Pathol Transl Med"],"published-print":{"date-parts":[[2025,11,15]]},"abstract":"<jats:p>Background: Gastric cancer remains a significant global health burden, with a high peritoneal recurrence rates after curative surgery. E-cadherin and the tumor-stroma ratio (TSR) have been proposed as prognostic indicators, but their combined prognostic utility remains unclear. Methods: This retrospective study included 130 patients with T3\/T4a gastric cancer who underwent curative gastrectomy at Ulsan University Hospital between 2014 and 2019. Immunohistochemistry for E-cadherin and Vimentin was performed. Digital image analysis using QuPath\u2019s object classifier quantified E-cadherin expression and TSR. Results: Low E-cadherin expression was associated with diffuse-type histology and advanced T stage. Low TSR was linked to younger age, female sex, and XELOX treatment. In Kaplan-Meier analysis, low TSR showed a non-significant trend toward higher peritoneal recurrence (p = .054), while low E-cadherin expression was significantly associated with increased peritoneal recurrence (p = .002). Combined biomarker analysis also revealed a significant difference in recurrence-free survival (RFS) among the four groups (p = .005); patients with both high TSR and high E-cadherin expression experienced the most favorable RFS. In multivariable analysis, E-cadherin expression remained the only independent predictor of peritoneal recurrence (high vs. low; hazard ratio, 0.348; 95% confidence interval, 0.149 to 0.816; p = .015). Conclusions: E-cadherin and TSR reflect distinct tumor biology such as epithelial integrity and stromal composition, and their combined evaluation improves prognostic stratification. Digital image analysis enhances reproducibility and objectivity, supporting their integration into clinical workflows.<\/jats:p>","DOI":"10.4132\/jptm.2025.08.27","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:25:41Z","timestamp":1762417541000},"page":"408-420","update-policy":"https:\/\/doi.org\/10.4132\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["E-cadherin expression and tumor-stroma ratio as prognostic biomarkers of peritoneal recurrence in advanced gastric cancer: a digital image analysis-based stratification study"],"prefix":"10.4132","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0208-0116","authenticated-orcid":true,"given":"Somang","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0934-3056","authenticated-orcid":true,"given":"Binnari","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2611","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2017.05.007"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31030109"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81735-1"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.689139"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.05.06"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.4032"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/ceg.s482377"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae124"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98857-1"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951201)76:11<2193::aid-cncr2820761104>3.0.co;2-2"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/or.4.4.743"},{"key":"ref13","first-page":"4234","volume-title":"Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer","author":"Yonemura","year":"2000"},{"key":"ref14","first-page":"13757","volume-title":"RhoA\/E-cadherin expression in gastric cancer patients: correlations with clinicopathological features and prognosis","author":"Xu","year":"2019"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2003.07.007"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-011-0004-x"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205929"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyab069"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-011-0041-5"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002040"},{"key":"ref21","first-page":"2693","volume-title":"Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients","author":"Li","year":"2014"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27947"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1379-1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52606-7"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0202-y"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13564-8"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1835"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15610"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.008"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.12.002"}],"container-title":["Journal of Pathology and Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jpatholtm.org\/upload\/pdf\/jptm-2025-08-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/jpatholtm.org\/journal\/view.php?doi=10.4132\/jptm.2025.08.27","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/jpatholtm.org\/upload\/pdf\/jptm-2025-08-27.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T04:08:48Z","timestamp":1763093328000},"score":1,"resource":{"primary":{"URL":"http:\/\/jpatholtm.org\/journal\/view.php?doi=10.4132\/jptm.2025.08.27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.4132\/jptm.2025.08.27","relation":{},"ISSN":["2383-7837","2383-7845"],"issn-type":[{"type":"print","value":"2383-7837"},{"type":"electronic","value":"2383-7845"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"2025-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}